SkyOak Wealth’s CVS Health CVS Stock Holding History

SkyOak Wealth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,525	Closed	-$208K	–	246
2024 Q2	$208K	Sell	3,525 -167	-5%	-$10.4K	0.05%	224
2024 Q1	$294K	Hold	3,692	–	–	0.07%	193
2023 Q4	$292K	Sell	3,692 -33	-0.9%	-$2.35K	0.08%	188
2023 Q3	$260K	Hold	3,725	–	–	0.08%	189
2023 Q2	$258K	Hold	3,725	–	–	0.07%	193
2023 Q1	$277K	Buy	3,725 +167	+5%	+$14K	0.08%	170
2022 Q4	$332K	Hold	3,558	–	–	0.11%	151
2022 Q3	$339K	Hold	3,558	–	–	0.12%	140
2022 Q2	$330K	Hold	3,558	–	–	0.11%	143
2022 Q1	$360K	Hold	3,558	–	–	0.1%	155
2021 Q4	$367K	Hold	3,558	–	–	0.09%	160
2021 Q3	$302K	Hold	3,558	–	–	0.08%	172
2021 Q2	$297K	Hold	3,558	–	–	0.08%	167
2021 Q1	$268K	Sell	3,558 -378	-10%	-$27.5K	0.07%	181
2020 Q4	$269K	Buy	+3,936	New	+$256K	0.08%	173

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SkyOak Wealth's CVS Position: Q3 2024 in Review

SkyOak Wealth sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,525 shares — an estimated $208K sold.

SkyOak Wealth first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $367K in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

SkyOak Wealth reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
SkyOak Wealth sold 3,525 CVS Health shares in Q3 2024, an estimated $208K.
SkyOak Wealth first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
SkyOak Wealth's CVS Health position peaked at $367K in Q4 2021.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on SkyOak Wealth's 13F filing for Q3 2024, filed 4 Nov 2024.